Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06993038 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adenosine vs Diltiazem for Treatment of SVT in the ED

Study acronym: COMFORT-ED
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary completion date: Jul 2026 to Jul 2027
    • Study completion date: Dec 2026 to Dec 2027
    v4
  2. Minor Start date changed from estimate of Aug 2025 to Aug 1, 2025v3
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date: Jul 2025 to Aug 2025
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a small, pilot study with a primary goal of assessing patient perceptions of two medication treatments for supraventricular tachycardia in adult patients treated in the Emergency Department.
Trial Details
NCT Number NCT06993038
Lead Sponsor Anne E. Zepeski
Conditions
(from sponsor)
Supraventricular Tachycardia (SVT)
Related terms Tachycardia, Supraventricular
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov